1. 277 ASXL1 GENE MUTATIONS ACCUMULATE IN AZACITIDINE-TREATED MDS PATIENTS AND ASSOCIATE WITH ADVERSE PROGNOSIS. Issue 1 (April 2015) Authors: Stopka, T.; Vargova, K.; Kulvait, V.; Vargova, J.; Dusilkova, N.; Jonasova, A. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ChemInform Abstract: Metal Free Carboamination of Internal Alkynes — An Easy Access to Polysubstituted Quinolines. Issue 34 (4th August 2016) Authors: Stopka, T.; Niggemann, M. Journal: ChemInform Issue: Volume 47:Issue 34(2016) Page Start: no Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cytogenetic Clonal Evolution in Myelodysplastic Syndromes (MDS) with Isolated Del(5Q). (April 2017) Authors: Zemanova, Z.; Michalova, K.; Brezinova, J.; Svobodova, K.; Lhotska, H.; Sarova, I.; Lizcova, L.; Izakova, S.; Ransdorfova, S.; Pavlistova, L.; Berkova, A.; Skipalova, K.; Belickova, M.; Siskova, M.; Neuwirtova, R.; Cermak, J.; Stopka, T.; Jonasova, A. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. High Level of Full-Length Cereblon Messenger RNA and Protein is Important for Lenalidomide Efficacy in Lower Risk MDS Patients. (April 2017) Authors: Fuchs, O.; Polak, J.; Bokorova, R.; Kostecka, A.; Vostry, M.; Neuwirtova, R.; Siskova, M.; Stopka, T.; Lauermannova, M.; Maaloufova, J. Soukupova; Salek, C.; Mikulenkova, D.; Cermak, J.; Brezinova, J.; Zemanova, Z.; Michalova, K.; Jonasova, A. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MDS Patients with Del(5Q) and Trisomy 8 in Two Independent Clones Have High fli-1 and Cereblon Messenger RNA Levels. (April 2017) Authors: Fuchs, O.; Polak, J.; Bokorova, R.; Kostecka, A.; Vostry, M.; Jonasova, A.; Myslivcova, D.; Siskova, M.; Stopka, T.; Lauermannova, M.; Salek, C.; Maaloufova, J. Soukupova; Mikulenkova, D.; Cermak, J.; Brezinova, J.; Zemanova, Z.; Michalova, K.; Neuwirtova, R. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Metal free carboamination of internal alkynes – an easy access to polysubstituted quinolines. Issue 33 (6th April 2016) Authors: Stopka, T.; Niggemann, M. Journal: Chemical communications Issue: Volume 52:Issue 33(2016) Page Start: 5761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PB1925: VENETOCLAX IN COMBINATION WITH AZACITIDINE OR LOW-DOSE CYTARABINE IN PATIENTS WITH HIGH-RISK MDS AND AML - EXPERIENCE OF A CZECH HAEMATOLOGY CENTRE. (23rd June 2022) Authors: Minarik, L.; Stopka, T.; Zemanova, Z.; Jonasova, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1804 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prediction potential of serum miR-155 and miR-24 for relapsing early breast cancer. (April 2018) Authors: Sochor, M.; Bašová, P.; Pešta, M.; Bartoš, J.; Stopka, T. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): MUTATIONS OF SF3B1 GENE AND ITS SIGNIFICANCE ON PATIENTS WITH MYELODYSPASTIC SYNDROMES (MDS). (May 2023) Authors: Zemanova, Z.; Aghova, T.; Lhotska, H.; Svobodova, K.; Hodanova, L.; Lizcova, L.; Pavlistova, L.; Luksikova, K.; Sotakova, S.; Minarik, L.; Stopka, T.; Jonasova, A. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: THE DEL(5Q) SIZE IN MDS IS CORRELATED TO KARYOTYPE COMPLEXITY AND FREQUENCY OF TP53 MUTATIONS. (September 2021) Authors: Zemanova, Z.; Brezinova, J.; Svobodova, K.; Lhotska, H.; Aghova, T.; Vidlakova, D.; Izakova, S.; Lizcova, L.; Ransdorfova, S.; Mendlikova, I.; Pavlistova, L.; Belickova, M.; Vesela, J.; Siskova, M.; Neuwirtova, R.; Cermak, J.; Stopka, T.; Jonasova, A. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗